Patient feedback on new cancer medicines for children
Part of Brain & nervous system, Cancer clinical trials.
This study asks children with cancer to share their experiences and symptoms while taking new, innovative medicines that are not yet standard. The goal is to learn how these treatments affect daily life, so doctors can better support children and families during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 2 and 18 years old.
- You must be able to read French, English, or Spanish (or your parents can read one of these languages, if you are older enough to answer yourself).
- You must already be enrolled in the SACHA study before starting your new cancer treatment.
- Your cancer must have relapsed, not responded to standard treatment, or you must have a type of cancer with no standard treatment options.
- You must not be participating in another early-phase clinical trial.
- You cannot have started the new treatment yet.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial helps children, teens, and young adults get an innovative cancer medicine when their disease has returned or hasn’t responded—and standard options are not available. It checks whether a “compassionate use” or off-label medicine plan can be carried out safely for the people who need it.
This trial helps children, teens, and young adults with cancer get early access to promising new drugs that are not yet fully approved for their age group. It collects information on how these drugs work in real-world use.
This trial uses lab-grown tumor samples from your child to test which chemotherapy drugs work best for their specific cancer. The goal is to find the most effective treatment by testing medicines on their tumor cells before giving them to your child.
This trial tests personalized cancer treatments for children and teens whose cancer has not responded to standard therapy. It uses information from precision medicine studies to match the right drug to each child's tumor.
This trial studies the genetic makeup of your tumor to find personalized treatment options, especially if standard treatments have not worked. It aims to match you with experimental treatments that target your cancer's specific changes.
This trial tests a combination of chemotherapy drugs (topotecan given into the spine plus maintenance chemo) for children under 6 with high-risk embryonal brain tumors. The goal is to see if this approach can improve outcomes after initial treatment.
Hear when a new CNS Tumor, Childhood trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.